Associated Papers
A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics.
Baou M et al.
Schizophrenia Research, 2016
Relationship between EGF, TGFA, and EGFR Gene Polymorphisms and Traditional Chinese Medicine ZHENG in Gastric Cancer.
Zhang J et al.
Evidence-based Complementary and Alternative Medicine : Ecam, 2013
The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis.
Clayden RC et al.
Translational Psychiatry, 2012
Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder.
Kamata M et al.
Journal of Affective Disorders, 2011
Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions.
Thomas KL et al.
Pharmacotherapy, 2009
[Association of tryptophan hydroxylase gene A218C and serotonin transporter gene polymorphism with essential hypertension in Chinese northern Han population].
Xia DS et al.
Zhonghua Xin Xue Guan Bing Za Zhi, 2009
Molecular epidemiology of major depressive disorder.
Kiyohara C et al.
Environmental Health and Preventive Medicine, 2009
Hyperserotonemia in autism: the potential role of 5HT-related gene variants.
Hranilović D et al.
Collegium Antropologicum, 2008
Lack of association between the serotonin transporter and tryptophan hydroxylase gene polymorphisms and completed suicide.
Mergen H et al.
Psychiatric Genetics, 2006
TPH gene polymorphism and aging: indication of combined effect on the predisposition to violent suicide.
Stefulj J et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2006
Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder.
You JS et al.
Psychiatric Genetics, 2005
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Mansour HA et al.
Annals of Medicine, 2005
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
Kirchheiner J et al.
Molecular Psychiatry, 2004
Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder.
Yoshida K et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2002
No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment.
Takahashi H et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 2002
Pharmacogenetics in affective disorders.
Serretti A et al.
European Journal of Pharmacology, 2002
Tryptophan hydroxylase gene 218A/C polymorphism is not associated with depressed suicide.
Du L et al.
The International Journal of Neuropsychopharmacology, 2000
Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder.
Mundo E et al.
American Journal of Medical Genetics, 2000
Search for association between suicide attempt and serotonergic polymorphisms.
Geijer T et al.
Psychiatric Genetics, 2000
Identification and analysis of new sequence variants in the human tryptophan hydroxylase (TpH) gene.
Paoloni-Giacobino A et al.
Molecular Psychiatry, 2000
Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)).
Gelernter J et al.
Genomics, 1998